Aesthetic device registration in Malaysia: where beauty ends and Act 737 begins.

Medical device, cosmetic or drug? The claim decides.

Under section 2 of the Medical Device Act 2012 (Act 737), a medical device is an article the manufacturer intends for a listed purpose. One of those purposes is “investigation, replacement or modification, or support of the anatomy or of a physiological process”. The device must not achieve its main intended action by pharmacological, immunological or metabolic means. Two things follow for aesthetics:

• The intended purpose you claim does the work. MDA's product-classification guideline says borderline decisions are based on the product's stated intended purpose and mode of action. It also warns that being a medical device in the US or EU does not make a product one in Malaysia. The Regulations also require the class to match the label, instructions for use, brochures and operating manuals. So the marketing copy is part of the regulatory file.
• Pharmacology moves it to NPRA. A product whose main action is pharmacological, such as botulinum toxin, is not a device at all. Drugs and cosmetics are regulated by the National Pharmaceutical Regulatory Agency (NPRA), not MDA.

Section 2 has a second limb. The Minister may declare any article used on the human body to be a medical device by gazetted order, after considering public safety, public health or public risk, whatever its purpose. That power has already been used on an aesthetic product. The Medical Device (Declaration) Order 2017 (P.U. (A) 339) made non-corrective contact lenses, including coloured and cosmetic lenses, medical devices from 1 January 2018.

A “non-medical device” entry assumes the product makes no medical claim. If the brochure starts saying “treats acne” or “removes scars”, you need to redo the analysis. When in doubt, MDA's product classification application decides device versus non-device. It has been fully online since 1 August 2026, and our classification guide covers how it works.

Lasers, HIFU and liposuction are now designated medical devices.

The Minister of Health made the Medical Device (Designated Medical Device) Order 2026 under section 26 of Act 737. That section lets the Minister designate a device after weighing its risk level, its exposure to public health, patient safety and its complexity. The Order was made on 8 January 2026, gazetted on 12 January 2026 as P.U. (A) 10, and came into operation on 1 June 2026. MDA's media statement of 9 January 2026 gave its purpose: to tighten control of devices used in aesthetic and beauty treatment, and to ensure that operators hold qualifications and skills recognised by the government. MDA had earlier linked the designation to a rise in complaints about aesthetic devices used by unqualified practitioners.

Every entry also covers “any other aesthetic purpose of use as determined by the manufacturer and in accordance with its intended use”. The list of purposes is illustrative, not a closed list.

What designation does, and what it does not do

• It controls who may operate the device. Under section 27, nobody may use or operate a designated device without a designated medical device permit. The penalty is a fine of up to RM100,000, up to one year in prison, or both. MDA grants permits for a prescribed period, can attach conditions, and permits can be renewed.
• It does not replace registration. A designated device is still a medical device. It must be registered under section 5 before it is imported or placed on the market, by an establishment holding a licence under section 15.
• It does not cover everything aesthetic. IPL, radiofrequency, cryolipolysis, microneedling, fillers and threads are not in the Schedule. They are not designated devices under this Order, but depending on their claims they can still be medical devices that need registration.
• It overtakes the ASEAN laser line for the listed types. The ASEAN borderline list treats a laser used only for aesthetic purposes as a non-medical device. The 2026 Order specifies seven laser types as medical devices for purposes that include hair removal and skin rejuvenation. For any laser type in the Schedule, we would not rely on the older borderline entry.

If you are buying one of the scheduled devices for a clinic or salon, check two things before paying: that the exact model is registered with MDA, and that whoever will operate it can hold a designated medical device permit. In 2024 MDA said it was developing guidance on the competency requirements and the permit application procedure. Confirm the current position with MDA before relying on any operator arrangement. If you are the supplier, the permit is the operator's obligation, not yours. But a customer who cannot lawfully operate the device is a commercial problem you will end up sharing.

How common aesthetic devices classify, and the rule behind each.

Classes come from the classification rules in the Medical Device Regulations 2012. Three points in those rules matter a lot for aesthetic devices. If more than one rule applies, the higher class wins. Devices used together are classified separately, so a handpiece or cartridge is classified in its own right. And “transient” means under 60 minutes, “short-term” means 60 minutes to 30 days, and “long-term” means more than 30 days of continuous use.

These are starting points, not verdicts. The class follows your intended-use wording. For anything borderline, we lodge the classification application first, before any dossier work. The classification guide explains grouping, which is how a laser platform with several handpieces is usually kept to a sensible number of registrations.

What the dossier has to prove for aesthetic devices.

Every registration shows conformity with the essential principles of safety and performance in the Medical Device Regulations 2012, set out in the CSDT dossier. The principles are the same for every device, but what they demand depends on the device family.

Energy-based devices: lasers, HIFU, RF, IPL, cryolipolysis

• Emitted radiation. Exposure has to be kept as low as practicable. Where a device emits hazardous levels on purpose, its settings must be reproducible within tolerance and the user must be able to control the emission. It should have visual or audible warnings where practicable. The operating instructions must explain the radiation, how to protect patient and user, and how to avoid misuse.
• Electromagnetic compatibility. The device must keep interference with other equipment as low as practicable, and must be adequately immune to disturbance itself.
• Electrical safety. No accidental electric shock, whether in normal use or when a single fault occurs.
• Software and programmable systems. They must be repeatable, reliable and perform as intended, with single-fault risks controlled.
• Handpieces, tips and cartridges sold separately. MDA's definition guidance (MDA/GD/0006) treats an accessory as a medical device in its own right, classified on its own risk. It may need its own registration.

Fillers, threads and dermal implants

• Materials. The dossier must address toxicity, compatibility with body tissue, substances that may leach out, and contaminants and residues.
• Sterility and infection control, in both the device and the manufacturing process.
• Absorption. The Regulations define absorption as breakdown in the body plus metabolic elimination of what it breaks down into. So for an absorbable filler or thread, expect to show evidence of how the material degrades and clears.
• Lidocaine and other medicinal substances. The safety, quality and usefulness of the substance must be verified. Under the MDA–NPRA combination product guideline, an invasive device–drug product first needs an NPRA endorsement letter, supported by an ancillary drug dossier. The applications can be filed at the same time, but MDA approval depends on receiving that endorsement.

Clinical evidence for aesthetic claims

The CSDT must contain a clinical evaluation showing the device is safe and performs as the manufacturer intends. That evaluation can come from a systematic review of the literature, clinical experience with the same or similar devices, or a clinical investigation. In aesthetics the pressure point is the claims list. Every purpose in the instructions for use needs support. A claim you cannot back is better cut from the labelling than defended in a query.

Clinics, distributors and beauty-equipment suppliers.

MDA has warned in writing that individuals and healthcare facilities importing unregistered devices and then offering treatment, therapy or diagnosis with them are placing devices on the market. The penalty is a fine of up to RM200,000, up to three years in prison, or both. Two exemptions are often misread by aesthetic businesses. The personal-use exemption excludes any device used on a third party. The demonstration-for-marketing exemption covers only activities that do not use the device on humans, so live demonstrations on volunteers fall outside it. Separately, the medical device import permit is enforced from 1 July 2027 and adds a per-shipment control on top of all of this.

Where aesthetic registrations go wrong.

• Relying on the ASEAN laser line after 1 June 2026. For the seven scheduled laser types, the Order now points the other way.
• Relying on an old classification letter. Letters issued before 2024 are no longer valid. Letters from 1 January 2024 to 31 May 2025 expire on 1 May 2027, and newer ones last up to two years.
• Letting marketing outrun the registration. The class has to match the label, instructions for use and brochures. A new claim on social media can move a product across the borderline, or up a class.
• Registering the console and forgetting the consumables. Handpieces, tips, cartridges and cannulae supplied separately are classified on their own and may need their own registration.
• Treating the lidocaine version as a variant of the plain filler. It follows a different rule (Rule 13), needs NPRA endorsement, and carries a different MDA registration fee.
• Assuming a CE mark or FDA clearance settles it. MDA's guideline says in terms that device status elsewhere does not decide device status in Malaysia. Foreign approvals help the dossier. They do not replace the Malaysian analysis.

What registering an aesthetic device costs.

Our fees are all-in: consultancy, CAB and MDA statutory fees in one figure. Class A is RM3,800 per device. MDA queries and resubmissions are handled within the quoted fee, and payment plans start from RM1,500 a month. Lidocaine fillers get a separate quotation because MDA's own registration fee for a device containing a medicinal product is RM5,000, against RM3,000 for a standard Class D, and there is an NPRA endorsement stage before it. The establishment licence and GDPMD are separate, business-level costs. Full schedule on pricing; the cost layers are explained in the cost guide.

Timeline. Registrations we manage are typically approved within 3 months once submitted. Before that clock starts:

• Classification, where needed. MDA's product-classification guideline gives a processing window of 30 working days from payment, longer if the product needs further discussion.
• CAB conformity assessment for Class B, C and D. If the device is already on Singapore's register, the Verification Route can shorten this step.
• NPRA endorsement for fillers containing lidocaine.

We have registered 1000+ devices with MDA since 2016. The step-by-step process guide shows where each stage sits, and our registration service runs it end to end.